3Love C J, Wilkoff BL, Byrd CL et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol, 2000;23:544.
4Darouiche RO. Trealment of infections ass iated with surgical implants. N Engl J Med, 2004;350:1422.
5Baddour LM, Epstein AE, Erickson CC et al. Update on cardiovascular implantahle electronic device infections and their management: a scientific statement from the American Heart Association. Circulation, 2010;121:458.
6Wilkoff BL, Love C J, Byrd CLet al. Transvenous lead extraction: Heart Rhythm S icty expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm, 2009;6:1085.
7Greenspon AJ, Patel JD, Lau E et al. 16-year trends in the infection burden for pacemakers and implantable cardi 111 the United States 1993 to 2008. J Am Coil Cardiol, 2011;58:1001.
8S.M. Kurtz, J.A. Ochoa, E. Lau et al.Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006.Pacing Clin Electrophysiol, 2011;33: 705.
9Arnold J. Greenspon, Jasmine D. Patel, Edmund Lau et al. Trends in Permanent Pacemaker Implantation in the United States From 1993 to 2009: Increasing Complexity of Patients and Procedures. J Am Coil Cardiol,60:1540.
10S.M. Kurtz, J.A. Ochoa, E. Lau et al.Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1992-2006. Paeing Clin Electrophysiol, 33:705.
